BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida. more
| Time Frame | BSEM | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 23.72% | 1.17% | 2.88% |
| 1-Month Return | 24.81% | 0.01% | 2.81% |
| 3-Month Return | -0.24% | 13.63% | 5.03% |
| 6-Month Return | -39.17% | 5.2% | 10.68% |
| 1-Year Return | -60.47% | 27.47% | 21.52% |
| 3-Year Return | 127.78% | 22.79% | 70.6% |
| 5-Year Return | 283.14% | 23.23% | 73.79% |
| 10-Year Return | -70.5% | 120.41% | 253.08% |
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 2.52M | 4.34M | 6.88M | 16.69M | 301.83M | [{"date":"2020-12-31","value":0.84,"profit":true},{"date":"2021-12-31","value":1.44,"profit":true},{"date":"2022-12-31","value":2.28,"profit":true},{"date":"2023-12-31","value":5.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Cost of Revenue | 1.27M | 1.47M | 881.75K | 1.26M | 13.75M | [{"date":"2020-12-31","value":9.24,"profit":true},{"date":"2021-12-31","value":10.73,"profit":true},{"date":"2022-12-31","value":6.41,"profit":true},{"date":"2023-12-31","value":9.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Gross Profit | 1.25M | 2.87M | 5.99M | 15.42M | 288.08M | [{"date":"2020-12-31","value":0.43,"profit":true},{"date":"2021-12-31","value":0.99,"profit":true},{"date":"2022-12-31","value":2.08,"profit":true},{"date":"2023-12-31","value":5.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Gross Margin | 49.64% | 66.03% | 87.17% | 92.45% | 95.45% | [{"date":"2020-12-31","value":52.01,"profit":true},{"date":"2021-12-31","value":69.18,"profit":true},{"date":"2022-12-31","value":91.33,"profit":true},{"date":"2023-12-31","value":96.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Expenses | 4.36M | 5.95M | 11.56M | 24.46M | 270.63M | [{"date":"2020-12-31","value":1.61,"profit":true},{"date":"2021-12-31","value":2.2,"profit":true},{"date":"2022-12-31","value":4.27,"profit":true},{"date":"2023-12-31","value":9.04,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Income | (1.84M) | (1.61M) | (4.68M) | (7.78M) | 31.20M | [{"date":"2020-12-31","value":-5.9,"profit":false},{"date":"2021-12-31","value":-5.15,"profit":false},{"date":"2022-12-31","value":-15,"profit":false},{"date":"2023-12-31","value":-24.93,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | - | 193.93K | (2.43M) | (704.01K) | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1254.17,"profit":false},{"date":"2023-12-31","value":-363.03,"profit":false},{"date":"2024-12-31","value":"-","profit":true}] |
| Pre-Tax Income | (2.37M) | (1.41M) | (7.11M) | (8.48M) | 30.61M | [{"date":"2020-12-31","value":-7.74,"profit":false},{"date":"2021-12-31","value":-4.61,"profit":false},{"date":"2022-12-31","value":-23.24,"profit":false},{"date":"2023-12-31","value":-27.71,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
| Income Taxes | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Income After Taxes | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (2.37M) | (1.41M) | (7.11M) | (8.48M) | 31.88M | [{"date":"2020-12-31","value":-7.43,"profit":false},{"date":"2021-12-31","value":-4.43,"profit":false},{"date":"2022-12-31","value":-22.31,"profit":false},{"date":"2023-12-31","value":-26.61,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Net Income | (2.39M) | (1.45M) | (7.07M) | (8.48M) | 31.88M | [{"date":"2020-12-31","value":-7.49,"profit":false},{"date":"2021-12-31","value":-4.53,"profit":false},{"date":"2022-12-31","value":-22.19,"profit":false},{"date":"2023-12-31","value":-26.61,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
| EPS (Diluted) | (0.75) | (0.19) | (0.58) | (0.48) | 1.82 | [{"date":"2020-12-31","value":-41.21,"profit":false},{"date":"2021-12-31","value":-10.29,"profit":false},{"date":"2022-12-31","value":-31.86,"profit":false},{"date":"2023-12-31","value":-26.37,"profit":false},{"date":"2024-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| BSEM | |
|---|---|
| Current Ratio | 4.31 |
| Quick Ratio | 4.09 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BSEM | |
|---|---|
| ROA (LTM) | -9.06% |
| ROE (LTM) | -48.64% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BSEM | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.20 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.80 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BSEM | |
|---|---|
| Trailing PE | 3.79 |
| Forward PE | 13.62 |
| P/S (TTM) | 1.81 |
| P/B | 1.13 |
| EV/R | 0.11 |
| EV/Ebitda | 2.08 |
| PEG | NM |
Biostem Technologies Inc (BSEM) share price today is $4.0928
Yes, Indians can buy shares of Biostem Technologies Inc (BSEM) on Vested. To buy
Yes, you can purchase fractional shares of Biostem Technologies Inc (BSEM) via the Vested app. You can start investing in Biostem Technologies Inc (BSEM) with a minimum investment of $1.
You can invest in shares of Biostem Technologies Inc (BSEM) via Vested in three simple steps:
The 52-week high price of Biostem Technologies Inc (BSEM) is $10.71. The 52-week low price of Biostem Technologies Inc (BSEM) is $3.01.
The price-to-earnings (P/E) ratio of Biostem Technologies Inc (BSEM) is 3.7925
The price-to-book (P/B) ratio of Biostem Technologies Inc (BSEM) is 1.13
The dividend yield of Biostem Technologies Inc (BSEM) is 0.00%
The market capitalization of Biostem Technologies Inc (BSEM) is $68.28M
The stock symbol (or ticker) of Biostem Technologies Inc is BSEM
Consider the share price of Biostem Technologies Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biostem Technologies Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Biostem Technologies Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biostem Technologies Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Biostem Technologies Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biostem Technologies Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
